Clinical Trial Update: A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 trial comparing dulaglutide with insulin glargine in type 2 diabetes mellitus completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dulaglutide (dulaglutide)
• Insulin Glargine (insulin glargine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2015-07-24